I-Hung Shih

I-hung Shih is a seasoned investment professional with extensive experience in the biopharmaceutical sector. Currently serving as Managing Director and Portfolio Manager at Eventide Asset Management since September 2024, I-hung previously held key roles at Wellington Management from October 2018 to August 2024, including Managing Director and Co-Head of Biotech Private Investments, Global Industry Analyst, and Portfolio Manager for Biotech. Prior to Wellington, I-hung worked as a Biotech Analyst at T. Rowe Price and served as a Board Observer for Homology Medicines Inc. From September 2014 to September 2016, I-hung was an Investment Professional at Temasek, focusing on US biopharma investments. I-hung holds an MBA from The Wharton School and a postdoctoral degree in Molecular and Cellular Biology from the Massachusetts Institute of Technology.